The evaluation of Remdesivir Utilization pattern and its correlation with clinical indicators in hospitalized patients during COVID
Background: In 2019 COVID became the cause of a pandemic, with approximately 500,000 deaths in six months worldwide. Remdesivir, the first drug approved by the U.S. Food and Drug Administration (FDA) for COVID-19 treatment, gained attention from numerous medical centers worldwide. Objective:The cons...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Research Center for Rational Use of Drugs (RCRUD),
2023-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |